Propylthiouracil: Difference between revisions
(Switch SMW query from broadtable to table format for better layout with TOC) |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 44: | Line 44: | ||
==Comments== | ==Comments== | ||
==Indications by Condition== | |||
''The following table is automatically generated from disease/condition pages across WikEM.'' | |||
{{#ask:[[Has DrugName::Propylthiouracil]] | |||
|?Has Indication=Indication | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|?Has Route=Route | |||
|?Has Population=Population | |||
|format=table | |||
|headers=plain | |||
|mainlabel=- | |||
|sort=Has Indication | |||
|limit=50 | |||
}} | |||
==See Also== | ==See Also== | ||
Latest revision as of 21:58, 20 March 2026
Administration
- Type: Antithyroid
- Dosage Forms:
- Routes of Administration:
- Other common names: PTU
Adult Dosing
- Thyroid storm: 500-1000mg PO loading dose, followed by 250mg PO q4h
- Hyperthyroidism
- Initial: 50-300mg PO TID (based on severity)
- Maintenance: 50mg PO TID
- 1st trimester pregnancy: Use lowest dose needed to keep maternal total T3/T4 slightly above normal range for pregnancy, TSH suppressed, and free T4 at or slightly above upper limit of normal for nonpregnant women. Switch to methimazole for 2nd-3rd trimester
Pediatric Dosing
- >6yo: 50 mg PO daily, carefully uptitrated
Special Populations
- Pregnancy Rating: D - see dosing note above
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing: No adjustment
- Hepatic dosing:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Both PTU and methimazole can cause agranulocytosis and hepatotoxicity, but to a lesser extent with methimazole
- Agranulocytosis, aplastic anemia
- Hepatotoxicity, liver failure
- Nephritis
- Vasculitis
Common
- Rash
Pharmacology
- Half-life: 0.9-4.3h
- Metabolism: Hepatic
- Excretion: Renal
Mechanism of Action
- Inhibits thyroperoxidase, blocking thyroid hormone synthesis in the thyroid. In target tissues, blocks 5'-deiodinase, thereby inhibiting conversion of T4 to active T3
Comments
Indications by Condition
The following table is automatically generated from disease/condition pages across WikEM.
| Indication | Dose | Context | Route | Population |
|---|---|---|---|---|
| Thyroid storm | 500-1000 mg PO/NG load, then 250 mg PO q4h | Thionamide (preferred, also blocks T4→T3) | PO/NG | Adult |
